CN Patent

CN104114572A — 经修饰的核苷、核苷酸和核酸组合物

Assigned to Moderna Inc · Expires 2014-10-22 · 12y expired

What this patent protects

本公开尤其提供了包含可以编码蛋白质、蛋白质前体或者所述蛋白质或蛋白质前体的经部分或完全加工的形式的经修饰的核酸分子的制剂组合物。所述制剂组合物还可以包括经修饰的核酸分子和递送剂。本发明还提供了可用于编码能够调节细胞功能和/或活性的多肽的核酸。

USPTO Abstract

本公开尤其提供了包含可以编码蛋白质、蛋白质前体或者所述蛋白质或蛋白质前体的经部分或完全加工的形式的经修饰的核酸分子的制剂组合物。所述制剂组合物还可以包括经修饰的核酸分子和递送剂。本发明还提供了可用于编码能够调节细胞功能和/或活性的多肽的核酸。

Drugs covered by this patent

Patent Metadata

Patent number
CN104114572A
Jurisdiction
CN
Classification
—
Expires
2014-10-22
Drug substance claim
No
Drug product claim
No
Assignee
Moderna Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.